Loading organizations...
§ Private Profile · Toronto, ON, Canada
Developer of handheld point-of-care analyzers for rapid blood testing and disease diagnosis, serving global health in remote settings.
Based in Toronto, Ontario, ChipCare develops a handheld point-of-care blood analyzer designed to deliver rapid diagnostic results for infectious and non-communicable diseases in remote healthcare settings. The portable device functions similarly to a commercial barcode scanner, providing on-the-spot monitoring of white blood cells to diagnose conditions such as HIV, malaria, sepsis, and various cancers. The company has secured two primary rounds of financing to refine and commercialize its diagnostic platform, including an initial $2.2 million seed round and a $2.05 million Phase II angel investment. These capital raises were backed by a syndicate of institutional funds and angel networks, featuring notable backers like Grand Challenges Canada, Maple Leaf Angels, and MaRS Innovation. While the exact founding year remains undisclosed, the medical diagnostics enterprise was originally co-founded by James Dou, Stewart Aitchison, and Rakesh Nayyar.
ChipCare has raised $7.1M across 2 funding rounds.
ChipCare has raised $7.1M in total across 2 funding rounds.
ChipCare has raised $7.1M across 2 funding rounds. Most recently, it raised $5.0M Series A in March 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 9, 2015 | $5M Series A | Puffin Partners | Epic Capital Management, Maple Leaf Angels, MaRS Innovation, Mindset Venture Group | Announced |
| Sep 17, 2013 | $2M Venture Round | — | Government OF Canada, Grand Challenges Canada, Maple Leaf Angels, MaRS Innovation, University OF Toronto | Announced |
ChipCare has raised $7.1M in total across 2 funding rounds.
ChipCare's investors include Puffin Partners, Epic Capital Management, Maple Leaf Angels, MaRS Innovation, Mindset Venture Group, Government of Canada, Grand Challenges Canada, University of Toronto.